PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 211 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $913 | -30.9% | 22,384 | -34.6% | 0.09% | -45.1% |
| Q4 2022 | $1,321 | -99.8% | 34,219 | +56.4% | 0.16% | -10.9% |
| Q1 2020 | $733,000 | +16.0% | 21,875 | +31.8% | 0.18% | +116.5% |
| Q3 2019 | $632,000 | -59.7% | 16,592 | -54.0% | 0.08% | -51.7% |
| Q2 2019 | $1,568,000 | +393.1% | 36,043 | +387.1% | 0.18% | +375.7% |
| Q4 2018 | $318,000 | -68.5% | 7,400 | -75.3% | 0.04% | -33.9% |
| Q2 2016 | $1,009,000 | +88.6% | 29,900 | +196.0% | 0.06% | +64.7% |
| Q1 2016 | $535,000 | -59.2% | 10,100 | -45.6% | 0.03% | -32.0% |
| Q2 2015 | $1,312,000 | -45.8% | 18,550 | -31.9% | 0.05% | -47.9% |
| Q1 2015 | $2,421,000 | +185.8% | 27,250 | +185.3% | 0.10% | +62.7% |
| Q4 2014 | $847,000 | -34.6% | 9,550 | -28.6% | 0.06% | -13.2% |
| Q3 2014 | $1,296,000 | -42.5% | 13,371 | -58.5% | 0.07% | -57.5% |
| Q1 2014 | $2,253,000 | +147.9% | 32,197 | +103.7% | 0.16% | +122.2% |
| Q4 2013 | $909,000 | +188.6% | 15,805 | +141.2% | 0.07% | +188.0% |
| Q3 2013 | $315,000 | -41.4% | 6,554 | -64.6% | 0.02% | -60.9% |
| Q2 2013 | $538,000 | – | 18,537 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |